学术探索
学术期刊
新闻热点
数据分析
智能评审

HIV vaccines - where are we going?

被引：50
作者：
Heilman, CA [1 ]
Baltimore, D
机构：
[1] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA
[2] CALTECH, Pasadena, CA 91125 USA
来源：
NATURE MEDICINE | 1998年 / 4卷 / 05期
关键词：
D O I：
10.1038/nm0598supp-532
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：532 / 534
页数：3
相关论文
共 38 条
  • [1] RAPID DEVELOPMENT OF ISOLATE-SPECIFIC NEUTRALIZING ANTIBODIES AFTER PRIMARY HIV-1 INFECTION AND CONSEQUENT EMERGENCE OF VIRUS VARIANTS WHICH RESIST NEUTRALIZATION BY AUTOLOGOUS SERA
    ALBERT, J
    ABRAHAMSSON, B
    NAGY, K
    AURELIUS, E
    GAINES, H
    NYSTROM, G
    FENYO, EM
    [J]. AIDS, 1990, 4 (02) : 107 - 112
  • [2] Phenotypic analysis of antigen-specific T lymphocytes
    Altman, JD
    Moss, PAH
    Goulder, PJR
    Barouch, DH
    McHeyzerWilliams, MG
    Bell, JI
    McMichael, AJ
    Davis, MM
    [J]. SCIENCE, 1996, 274 (5284) : 94 - 96
  • [3] PATHOGENICITY OF LIVE, ATTENUATED SIV AFTER MUCOSAL INFECTION OF NEONATAL MACAQUES
    BABA, TW
    JEONG, YS
    PENNINCK, D
    BRONSON, R
    GREENE, MF
    RUPRECHT, RM
    [J]. SCIENCE, 1995, 267 (5205) : 1820 - 1825
  • [4] Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians
    Betts, MR
    Krowka, J
    Santamaria, C
    Balsamo, K
    Gao, F
    Mulundu, G
    Luo, CW
    NGandu, N
    Sheppard, H
    Hahn, BH
    Allen, S
    Frelinger, JA
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (11) : 8908 - 8911
  • [5] A vaccine for HIV type 1: The antibody perspective
    Burton, DR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (19) : 10018 - 10023
  • [6] Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: Implications for vaccine development
    Cao, HY
    Kanki, P
    Sankale, JL
    DiengSarr, A
    Mazzara, GP
    Kalams, SA
    Korber, B
    Mboup, S
    Walker, BD
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (11) : 8615 - 8623
  • [7] VIROLOGICAL AND IMMUNOLOGICAL CHARACTERIZATION OF LONG-TERM SURVIVORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    CAO, YZ
    QIN, LM
    ZHANG, LQ
    SAFRIT, J
    HO, DD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) : 201 - 208
  • [8] Analysis of the human env-specific cytotoxic T-lymphocyte (CTL) response in natural human immunodeficiency virus type 1 infection: Low prevalence of broadly cross-reactive env-specific CTL
    Carmichael, A
    Jin, X
    Sissons, P
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (12) : 8468 - 8476
  • [9] GENOMIC STRUCTURE OF AN ATTENUATED QUASI-SPECIES OF HIV-1 FROM A BLOOD-TRANSFUSION DONOR AND RECIPIENTS
    DEACON, NJ
    TSYKIN, A
    SOLOMON, A
    SMITH, K
    LUDFORDMENTING, M
    HOOKER, DJ
    MCPHEE, DA
    GREENWAY, AL
    ELLETT, A
    CHATFIELD, C
    LAWSON, VA
    CROWE, S
    MAERZ, A
    SONZA, S
    LEARMONT, J
    SULLIVAN, JS
    CUNNINGHAM, A
    DWYER, D
    DOWTON, D
    MILLS, J
    [J]. SCIENCE, 1995, 270 (5238) : 988 - 991
  • [10] Evaluation of monoclonal antibodies to human immunodeficiency virus type 1 primary isolates by neutralization assays: Performance criteria for selecting candidate antibodies for clinical trials
    DSouza, MP
    Livnat, D
    Bradac, JA
    Bridges, SH
    Bryson, Y
    Hanson, C
    Matthews, T
    Moore, J
    Trkola, A
    ZollaPazner, S
    Gorny, M
    Burton, D
    Merigan, T
    McNamara, J
    Norcross, M
    Posner, M
    Robinson, J
    ViraniKetter, N
    Barbas, CF
    Parren, P
    Katinger, H
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (05) : 1056 - 1062
1234